Quantitative Structure Activity Relationship Studies of Benzoxazinone Derivative Antithrombotic Drug Using New Three-dimensional Structure Descriptors

被引:0
|
作者
仝建波 [1 ,2 ]
李云飞 [1 ,2 ]
刘淑玲 [1 ,2 ]
孟元亮 [1 ,2 ]
机构
[1] Key Laboratory of Auxiliary Chemistry & Technology for Chemical Industry,Ministry of Education,Shaanxi University of Science & Technology
[2] College of Chemistry & Chemical Engineering,Shaanxi University of Science & Technology
关键词
benzoxazinone derivatives; antithrombotic drug; three-dimensional holographic vector of atomic interaction field(3D-HoVAIF); quantitative structure-activity relationship(QSAR);
D O I
10.14102/j.cnki.0254-5861.2010.12.027
中图分类号
TQ460.1 [基础理论]; R91 [药物基础科学];
学科分类号
1007 ;
摘要
A novel three-dimensional holographic vector of atomic interaction field(3D-HoVAIF) was used to describe the chemical structures of 23 benzoxazinone derivatives as antithrombotic drugs.Here a quantitative structure activity relationship(QSAR) model was built by partial least-squares(PLS) regression.The estimation stability and prediction ability of the model were strictly analyzed by both internal and external validations.The correlation coefficients of established PLS model,leave-one-out(LOO) cross-validation,and predicted values versus experimental ones of external samples were R2=0.899,RCV2=0.854 and Qext2=0.868,respectively.These values indicated that the built PLS model had both favorable estimation stability and good prediction capabilities.Furthermore,the satisfactory results showed that 3D-HoVAIF could preferably express the information related to the biological activity of benzoxazinone derivatives.
引用
收藏
页码:1893 / 1899
页数:7
相关论文
共 50 条
  • [41] Three-dimensional quantitative structure activity relationship computational approaches for prediction of human in vitro intrinsic clearance
    Ekins, S
    Obach, RS
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2000, 295 (02): : 463 - 473
  • [42] Two- and Three-dimensional Quantitative Structure-activity Relationship Models Based on Conformer Structures
    Nitta, Fumika
    Kaneko, Hiromasa
    MOLECULAR INFORMATICS, 2021, 40 (03)
  • [43] Three-dimensional quantitative structure activity relationship analysis of anilinoquinazolines for c-Src kinase inhibition
    Pratigya Silakari
    Savitri Devi Srivastava
    Dharam Veer Kohli
    Santosh Kumar Srivastava
    Gyati Silakari
    Bhawna Vyas
    Om Silakari
    Medicinal Chemistry Research, 2011, 20 : 158 - 167
  • [44] Applications of the Method of Three-dimensional Projection of a Molecule in Quantitative Structure-activity Relationship of Phenol Derivatives
    Zhang, Qing-You
    Xu, Lu
    Kao Teng Hsueh Hsiao Hua Heush Hsueh Pao/ Chemical Journal of Chinese Universities, 2002, 23 (11):
  • [45] Three-dimensional quantitative structure-activity relationship analyses of RGD mimetics as fibrinogen receptor antagonists
    Miyashita, M
    Akamatsu, M
    Hayashi, Y
    Ueno, T
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (09) : 859 - 863
  • [46] Three-dimensional quantitative structure-activity relationship analysis of human CYP51 inhibitors
    Ekins, Sean
    Mankowski, Dayna C.
    Hoover, Dennis J.
    Lawton, Michael P.
    Treadway, Judith L.
    Harwood, H. James, Jr.
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (03) : 493 - 500
  • [47] Antileishmanial chalcones: Statistical design, synthesis, and three-dimensional quantitative structure-activity relationship analysis
    Nielsen, SF
    Christensen, SB
    Cruciani, G
    Kharazmi, A
    Liljefors, T
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (24) : 4819 - 4832
  • [48] Three-dimensional quantitative structure activity relationship analyses of substrates for CYP2B6
    Ekins, S
    Bravi, G
    Ring, BJ
    Gillespie, TA
    Gillespie, JS
    Vandenbranden, M
    Wrighton, SA
    Wikel, JH
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1999, 288 (01): : 21 - 29
  • [49] Three-dimensional quantitative structure activity relationship analysis of anilinoquinazolines for c-Src kinase inhibition
    Silakari, Pratigya
    Srivastava, Savitri Devi
    Kohli, Dharam Veer
    Srivastava, Santosh Kumar
    Silakari, Gyati
    Vyas, Bhawna
    Silakari, Om
    MEDICINAL CHEMISTRY RESEARCH, 2011, 20 (02) : 158 - 167
  • [50] Three-dimensional quantitative structure-activity relationship of 1,4-dihydropyridines as antitubercular agents
    Kharkar, PS
    Desai, B
    Gaveria, H
    Varu, B
    Loriya, R
    Naliapara, Y
    Shah, A
    Kulkarni, VM
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (22) : 4858 - 4867